| Curt C Carlier, MD | |
|
484 Harleysville Pike, Harleysville, PA 19438-2210 | |
| (215) 256-8040 | |
| Not Available |
| Full Name | Curt C Carlier |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 484 Harleysville Pike, Harleysville, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942254040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD066167L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grand View Home Care | Sellersville, PA | Home health agency |
| Grand View Hospice | Sellersville, PA | Hospice |
| Grand View Hospital | Sellersville, PA | Hospital |
| Peter Becker Community | Harleysville, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novacare Outpatient Rehabilitation East Inc | 3678480290 | 617 |
| Trivalley Primary Care Pc | 4981680923 | 55 |
News Archive
What makes stem cells develop into kidneys? Lori O'Brien, a postdoctoral research associate in the laboratory of Andy McMahon, has received the first Broad Fellowship to help answer this question.
In a new study, published in the journal JAMA Network, University of Pittsburgh researchers for the Global Consortium Study of Neurologic Dysfunction in COVID-19 found that neurological manifestations were prevalent among patients hospitalized with COVID-19. The patients were also at a higher risk of in-hospital mortality.
The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU's Institute for Advancing Medical Innovation.
Detailed results from the Prime-Boost HIV Vaccine Clinical Trial involving more than 16,000 adult volunteers in Thailand show that an investigational HIV vaccine regimen was safe and modestly effective at reducing the rate of HIV infection compared to placebo.
The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard- against the human papillomavirus, which causes cervical cancer. The research will evaluate the efficacy of Carraguard- - a clear gel made from the seaweed derivative carrageenan - in preventing new HPV infections in women.
› Verified 4 days ago
| Entity Name | Trivalley Primary Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245295757 PECOS PAC ID: 4981680923 Enrollment ID: O20040629000657 |
News Archive
What makes stem cells develop into kidneys? Lori O'Brien, a postdoctoral research associate in the laboratory of Andy McMahon, has received the first Broad Fellowship to help answer this question.
In a new study, published in the journal JAMA Network, University of Pittsburgh researchers for the Global Consortium Study of Neurologic Dysfunction in COVID-19 found that neurological manifestations were prevalent among patients hospitalized with COVID-19. The patients were also at a higher risk of in-hospital mortality.
The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU's Institute for Advancing Medical Innovation.
Detailed results from the Prime-Boost HIV Vaccine Clinical Trial involving more than 16,000 adult volunteers in Thailand show that an investigational HIV vaccine regimen was safe and modestly effective at reducing the rate of HIV infection compared to placebo.
The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard- against the human papillomavirus, which causes cervical cancer. The research will evaluate the efficacy of Carraguard- - a clear gel made from the seaweed derivative carrageenan - in preventing new HPV infections in women.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Curt C Carlier, MD 484 Harleysville Pike, Harleysville, PA 19438-2210 Ph: (215) 256-8040 | Curt C Carlier, MD 484 Harleysville Pike, Harleysville, PA 19438-2210 Ph: (215) 256-8040 |
News Archive
What makes stem cells develop into kidneys? Lori O'Brien, a postdoctoral research associate in the laboratory of Andy McMahon, has received the first Broad Fellowship to help answer this question.
In a new study, published in the journal JAMA Network, University of Pittsburgh researchers for the Global Consortium Study of Neurologic Dysfunction in COVID-19 found that neurological manifestations were prevalent among patients hospitalized with COVID-19. The patients were also at a higher risk of in-hospital mortality.
The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU's Institute for Advancing Medical Innovation.
Detailed results from the Prime-Boost HIV Vaccine Clinical Trial involving more than 16,000 adult volunteers in Thailand show that an investigational HIV vaccine regimen was safe and modestly effective at reducing the rate of HIV infection compared to placebo.
The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard- against the human papillomavirus, which causes cervical cancer. The research will evaluate the efficacy of Carraguard- - a clear gel made from the seaweed derivative carrageenan - in preventing new HPV infections in women.
› Verified 4 days ago
Gerald Winfield Hedrick, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 815 Maplewood Drive, Apt 368, Harleysville, PA 19438 Phone: 215-703-4170 | |
Nazely Khandkar, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 658 Harleysville Pike, Harleysville, PA 19438 Phone: 215-256-9655 | |
Dr. Suzann Szewczak, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 658 Harleysville Pike, Suite 120, Harleysville, PA 19438 Phone: 215-256-9655 Fax: 215-256-9868 | |
Ralph Lawrence Derstine, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 488 Harleysville Pike, Harleysville, PA 19438 Phone: 215-256-9445 Fax: 215-256-4857 | |
Dr. Susan K Underwood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 484 Harleysville Pike, Harleysville, PA 19438 Phone: 215-256-8040 | |
Dr. Mary Ann Karp, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 176 Main St, Harleysville, PA 19438 Phone: 215-256-9531 Fax: 215-256-9134 | |
Dr. Richard J Pierotti, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 484 Harleysville Pike, Harleysville, PA 19438 Phone: 215-256-8040 |